ISCHEMIA TECHNOLOGIES
Ischemia Technologies is a Denver-based provider of diagnostic tests for cardiovascular and acute care medicines.
ISCHEMIA TECHNOLOGIES
Industry:
Biotechnology Health Care
Founded:
1997-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Status:
Active
Total Funding:
0
Current Advisors List
Investors List
Advantage Capital
Advantage Capital investment in Venture Round - Ischemia Technologies
More informations about "Ischemia Technologies"
HOME | Ischemia
The Biomarkers of Acute Stroke Etiology (BASE) was a 1,700 patient prospective IRB approved observational multisite clinical trial (NCT02014896) that concluded enrollment in 2020 designed to validate the use of biomarkers in the acute …See details»
ISCHEMIA TECHNOLOGIES INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ISCHEMIA TECHNOLOGIES INC of Arvada, CO. Get the latest business insights from Dun & Bradstreet.See details»
Ischemia Technologies - PitchBook
Ischemia Technologies General Information Description. Developer of vitro diagnostic products. The company develops, manufactures and markets diagnostic devices for vitro diagnostic …See details»
Ischemia Technologies - Products, Competitors, Financials, …
Ischemia Technologies was a Healthcare/Medical Equipment & Supplies company based in Denver, Colorado. Use the CB Insights Platform to explore Ischemia Technologies's full …See details»
Ischemia Technologies - Crunchbase
Ischemia Technologies is a Denver-based provider of diagnostic tests for cardiovascular and acute care medicines. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Ischemia Technologies, Inc. - Drug pipelines, Patents, Clinical trials ...
Last update 08 Mar 2025. Ischemia Technologies, Inc. Private Company |See details»
BioPharmaLink profile of Ischemia Technologies, Inc., United …
Ischemia Technologies is developing and commercializing proprietary and patented technology for a new blood test for ischemia, with an initial focus on cardiac ischemia. Existing cardiac …See details»
Ischemia Technologies - 2025 Company Profile - Tracxn
Apr 26, 2025 Ischemia Technologies is a deadpooled company based in Waltham (United States), founded in 1997. It operates as a Develops, manufactures, and markets in vitro …See details»
Ischemia Technologies, Inc.:Company Profile & Technical Research ...
Ischemia Technologies, Inc. is a company that provides Ischemia, Medicine, Diagnostic test and more. Ischemia Technologies, Inc. is headquartered in United States Massachusetts. Ischemia …See details»
Ischemia Technologies, Inc - VentureRadar
Flashback Technologies USA Privately Held Our mission is to discover, develop and commercialize product applications of our CipherSensor™ computational engine that provide …See details»
Ischemia Technologies Inc - Company Profile and News
Company profile page for Ischemia Technologies Inc including stock price, company news, executives, board members, and contact informationSee details»
Ischemia Technologies - Overview, News & Similar companies
Who is Ischemia Technologies. Ischemia Technologies develops, manufactures and markets new and unique in vitro diagnostic products with a focus on cardiovascular and acute care …See details»
Ischemia Technologies - Raised $12.7M Funding from 5 investors
Mar 10, 2025 Ischemia Technologies has raised a total funding of $12.7M over 3 rounds from 5 investors. Investors include Advantage Capital, Plymouth Growth and 3 others. Their latest …See details»
Ischemia Technologies - Contacts, Employees, Board Members, …
Ischemia Technologies is a Denver-based provider of diagnostic tests for cardiovascular and acute care medicines. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
Optimised medical therapy alone versus optimised medical …
TJvV and PJN report grant funding for ECST-2 and a Dutch cost-effectiveness substudy from the Dutch Organisation for Knowledge and Innovation in Health, Healthcare and Well-Being. ...See details»
A molecular brain atlas reveals cellular shifts during the repair …
Apr 18, 2025 Ischemic stroke triggers a cascade of pathological events that affect multiple cell types and often lead to incomplete functional recovery. Despite advances in single-cell …See details»
Advances in treatments for acute ischemic stroke | The BMJ
3 days ago Acute ischemic stroke is a leading global cause of death and disability. Intravenous thrombolysis was the first acute treatment developed for ischemic strokes. First with alteplase …See details»
Thrombolysis for acute ischaemic stroke: development and update
Apr 28, 2025 Introduction. Stroke remains a major contributor to the global disease burden, consistently ranking among the leading causes of morbidity from 2010 to 2021. 1 Ischaemic …See details»
Empowerment and mobile technology in the detection and …
Mar 14, 2025 Background Hypertension and atrial fibrillation (AF) are major treatable risk factors for ischemic stroke and transient ischemic attack (TIA). However, most of the patients with an …See details»
Use of Robot-Assisted Thrombectomy System in Acute Ischemic …
Apr 7, 2025 Mechanical thrombectomy (MT) has proven highly effective in treating acute ischemic stroke due to large vessel occlusion (AIS-LVO). 1 Robot-assisted technology has …See details»